G 拜 克2006年第一季度报告

股票简称:G拜克                          股票代码：600226

                浙江升华拜克生物股份有限公司2006年第一季度报告

     1重要提示
     1.1本公司董事会及其董事保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。
     1.2公司董事康列克因工作原因未能出席，未授权其他董事代为表决。
     1.3公司第一季度财务报告未经审计。
     1.4公司负责人吴梦根,主管会计工作负责人陈俊标,会计机构负责人杨春芳声明：保证本季度报告中财务报告的真实、完整。
     2公司基本情况简介
     2.1公司基本信息
   
           股票简称               G拜克           变更前简称(如有)            升华拜克
           股票代码                                       600226
                                           董事会秘书                       证券事务代表
             姓名           唐劲然                                    徐芬
           联系地址         浙江省德清县钟管工业区                    浙江省德清县钟管工业区
             电话           0572-8402738                              0572-8402738
             传真           0572-8402738                              0572-8402738
           电子信箱         tjr@biok.com                              xuf123456@sina.com
   2.2财务资料
   2.2.1主要会计数据及财务指标
                                                                                    币种:人民币
                                                                                本报告期末比上
                                             本报告期末        上年度期末数      年度期末增减
                                                                                    （％）
    总资产(元)                            1,727,538,242.53   1,716,518,776.31              0.64
    股东权益（不含少数股东权益）(元)        938,979,653.69     908,705,464.44              3.33
    每股净资产(元)                                    3.47               3.36             3.27
    调整后的每股净资产(元)                            3.46               3.35             3.28
                                                                                本报告期比上年
                                               报告期        年初至报告期期末
                                                                                同期增减（％）
    经营活动产生的现金流量净额(元)          -24,926,519.10     -24,926,519.10             42.82
    每股收益(元)                                      0.06               0.06             14.29
                                                                                减少0.38个百
    净资产收益率(%)                                   1.72               1.72
                                                                                分点
    扣除非经常性损益后的净资产收益率                                            减少0.62个百
                                                      1.48               1.48
     (%)                                                                        分点
                          非经常性损益项目                                                              金额（单位：元）
    处置长期股权投资、固定资产、在建工程、无形资产、其他长期资                                         -155,842.66
    产产生的损益
    各种形式的政府补贴                                                                                2,510,000.00
    短期投资收益，（不包括经国家有关部门批准设立的有经营资格的
                                                                                                        498,282.25
    金融机构获得的短期投资收益）
    扣除公司日常根据企业会计制度规定计提的资产减值准备后的其他
                                                                                                       -389,427.06
    各项营业外收入、支出
    所得税影响数                                                                                       -227,958.38
    减：少数股东损益                                                                                    -37,734.47
    合计                                                                                              2,272,788.62
   2.2.2利润表
                                                                    单位:元币种:人民币审计类型:未经审计
                                                            合并                                母公司
                     项目
                                                  本期数          上年同期数           本期数          上年同期数
    一、主营业务收入                          386,042,303.11    370,479,219.07     214,222,895.35     181,933,612.21
    减：主营业务成本                           328,710,312.40    305,331,684.90     176,140,967.62    141,757,005.06
    主营业务税金及附加                           1,233,758.78      1,127,813.32       1,233,758.78      1,006,934.65
    二、主营业务利润（亏损以“-”号填
                                               56,098,231.93      64,019,720.85      36,848,168.95     39,169,672.50
    列）
    加：其他业务利润（亏损以“-”号填
                                                1,246,793.22         510,636.17       1,313,916.42        767,041.46
    列）
    减:营业费用                                  6,189,362.39     10,774,907.55       3,494,309.10      5,918,573.14
    管理费用                                    24,194,184.97     20,771,372.46      16,862,752.80     15,551,436.07
    财务费用                                     3,126,129.94      2,745,692.59         506,385.95      1,185,108.81
    三、营业利润（亏损以“-”号填列）           23,835,347.85     30,238,384.42      17,298,637.52     17,281,595.94
    加：投资收益（损失以“-”号填列）            1,673,508.61       -292,762.11       3,818,170.51      5,333,940.28
    补贴收入                                                         350,475.48
    营业外收入                                         600.00          1,003.85             600.00          1,003.85
    减：营业外支出                                 545,869.72        106,533.90         423,075.92         48,090.11
    四、利润总额（亏损总额以“-”号填
                                               24,963,586.74      30,190,567.74      20,694,332.11     22,568,449.96
    列）
    减：所得税                                   8,089,032.34     11,154,393.46       6,033,160.65      6,687,745.05
    减：少数股东损益                               700,971.82        940,258.73
    加：未确认投资损失(合并报表填列)
    五、净利润（亏损以“-”号填列）             16,173,582.58     18,095,915.55      14,661,171.46     15,880,704.91
   2.3报告期末股东总数及前十名无限售条件流通股股东持股表(已完成股权分置改革)
                                                                                                            单位：股
    报告期末股东总数（户）                                                                                    30,536
                                      前十名无限售条件流通股股东持股情况
                                            期末持有无限售条
             股东名称(全称)                                       种类
                                          件流通股的数量
    顾平                                      700,100     人民币普通股
    蔡欣                                      495,000     人民币普通股
    吕剑锋                                    408,674     人民币普通股
    李静文                                    322,650     人民币普通股
    邝振番                                    312,000     人民币普通股
    朱家瑶                                    299,566     人民币普通股
    史化民                                    290,810     人民币普通股
    郑黎明                                    267,526     人民币普通股
    宋延军                                    261,560     人民币普通股
    金宽荣                                    250,000     人民币普通股
   
      3管理层讨论与分析
     3.1公司报告期内经营活动总体状况的简要分析
       报告期内，公司完成主营业务收入386,042,303.11元，同比增长4.2%；实现净利润16,173,582.58元，同比下降10.62%。其中农药业务保持了基本稳定的发展态势，实现销售收入18024万元，同比增长5.24%；另一方面，受全球禽流感的影响，公司兽药及医药中间体价格有所下滑，毛利率分别为17.12%、19.12%，同比分别下降了7.45个百分点、24.51个百分点；锆系列产品价格同比有所回落，毛利率为15.73%，同比下降7.69个百分点。
       报告期内，公司120吨阿维菌素及系列产品项目已完成并投产。
     3.1.1占主营收入或主营业务利润总额10%以上的主营行业或产品情况
     √适用□不适用
   
                                                        单位:元币种:人民币审计类型:未经审计
                                        主营业务收入                主营业务成本           毛利率(%)
           分行业
    农药                              180,240,411.75             156,757,802.52          13.03
    锆系列                             89,290,337.93              75,242,100.09          15.73
    兽药                               43,340,290.73              35,921,210.01          17.12
    化学原料                           35,222,525.11              31,946,111.76           9.30
    农药中间体                          9,811,322.06               6,486,765.85          33.88
    医药中间体                         19,016,726.34              15,380,048.72          19.12
           分产品
    麦草畏                             43,528,927.82              29,100,323.05          33.15
    氧氯化锆                           60,743,742.79              50,605,160.63          16.69
    其中:关联交易                       1,085,607.33                 781,115.68          28.05
      关联交易的定价原则     按照双方签订的关联交易协议
   
     3.1.2公司经营的季节性或周期性特征
     □适用√不适用
     3.1.3报告期利润构成情况（主营业务利润、其他业务利润、期间费用、投资收益、补贴收入与营业外收支净额在利润总额中所占比例与前一报告期相比的重大变动及原因的说明）
     √适用□不适用
       报告期内，投资收益占利润总额比例为6.7%,比去年同期的-0.96%增长了7.66个百分点。增长的原因是因为报告期内公司参股公司青岛易邦生物工程有限公司实现净利润488万元，贡献投资收益185万元；短期投资收益49.82万元。
     3.1.4主营业务及其结构与前一报告期相比发生重大变化的情况及原因说明
     □适用√不适用
     3.1.5主营业务盈利能力（毛利率）与前一报告期相比发生重大变化的情况及其原因说明
     □适用√不适用
     3.2重大事项及其影响和解决方案的分析说明
     □适用√不适用
     3.3会计政策、会计估计、合并范围变化以及重大会计差错的情况及原因说明
     □适用√不适用
     3.4经审计且被出具"非标意见"情况下董事会和监事会出具的相关说明
     □适用√不适用
     3.5预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示
     及原因说明
     □适用√不适用
     3.6公司对已披露的年度经营计划或预算的滚动调整情况
     □适用√不适用
     3.7公司原非流通股东在股权分置改革过程中做出的特殊承诺及其履行情况
     √适用□不适用
   
                                                                                               承诺
   股东名
                                                特殊承诺                                       履行
     称
                                                                                               情况
            升华集团承诺：现持有的升华拜克股份自获得上市流通权之日起，36个月内不上市交易
            或转让；在该项承诺期满后24个月内，通过交易所挂牌交易出售股份的价格不低于8
   升华集   元（当升华拜克派发红股、转增股本、增资扩股、配股、派息等情况使股份数量或股东
   团控股   权益发生变化时，最低减持价格相应调整）。若升华集团违反限价减持承诺出售持有的
   有限公   原非流通股股份，升华集团同意登记结算公司将出售股份所得资金划入升华拜克帐户归
   司       全体股东所有；升华集团将在2006年、2007年、2008年连续三年的年度股东大会上提
            出当年现金分红总额不低于当年实现的经审计可分配净利润（非累计可分配利润）的
            50%的利润分配议案，并保证在股东大会表决时对该议案投赞成票。
   天津鸿
            鸿基置业特别承诺：在办理持有的非流通股股份上市流通时，应先履行其与升华集团和
   基置业
            源裕投资三方签订的协议书中约定的义务，并按照上海证券交易所的有关规定提出该等
   有限公
            股份的上市流通申请。
   司
   
   浙江升华拜克生物股份有限公司
   法定代表人：吴梦根
   2006年4月18日
   
      4附录
                                                      资产负债表
                                                  2006年3月31日
     编制单位:浙江升华拜克生物股份有限公司
   
                                                                    单位:元币种:人民币审计类型:未经审计
                                                      合并                                    母公司
                 项目
                                          期末数               期初数               期末数               期初数
    流动资产：
    货币资金                            216,167,790.45       275,797,014.93        40,262,977.64       55,350,220.35
    短期投资                                                   5,000,000.00                             5,000,000.00
    应收票据                             13,974,868.50        11,664,100.03        13,424,868.50       11,664,100.03
    应收股利
    应收利息
    应收账款                            277,721,818.72       198,810,302.26       132,683,492.57       94,309,952.88
    其他应收款                           10,532,697.44         4,455,625.71         5,764,650.61        4,960,425.76
    预付账款                             22,724,044.94        25,726,704.21        12,982,825.16       19,216,636.39
    应收补贴款                           13,640,614.57        14,945,627.97                             2,289,363.35
    存货                                153,885,713.34       171,402,033.53       110,558,027.56      129,035,706.86
    待摊费用                                419,890.95           829,723.29           274,212.21          717,907.45
    一年内到期的长期债权投资
    其他流动资产
    流动资产合计                        709,067,438.91       708,631,131.93       315,951,054.25      322,544,313.07
    长期投资：
    长期股权投资                         60,101,793.07        58,926,566.71       175,316,715.32      157,934,830.39
    长期债权投资
    长期投资合计                         60,101,793.07        58,926,566.71       175,316,715.32      157,934,830.39
    其中：合并价差                        4,503,684.27         4,679,152.47
    其中：股权投资差额                    6,874,277.06         7,142,106.02        11,377,961.33       11,821,258.49
    固定资产：
    固定资产原价                      1,083,876,425.92       926,112,795.51       990,205,732.05      834,048,961.20
    减：累计折旧                        234,389,711.25       218,961,146.01       214,077,269.89      200,825,969.40
    固定资产净值                        849,486,714.67      707,151,649.50       776,128,462.16       633,222,991.80
    减：固定资产减值准备                  5,215,339.60         5,717,571.76         3,555,720.72        4,057,952.88
    固定资产净额                        844,271,375.07      701,434,077.74       772,572,741.44       629,165,038.92
    工程物资                              6,571,248.02         4,418,772.10         4,635,673.26        2,168,466.99
    在建工程                             75,272,981.00       209,292,145.68        21,099,748.49      162,807,976.06
    固定资产清理
    固定资产合计                        926,115,604.09       915,144,995.52       798,308,163.19      794,141,481.97
    无形资产及其他资产：
    无形资产                             31,479,399.51        31,760,248.15        16,530,159.50       16,622,916.92
    长期待摊费用                            774,006.95         2,055,834.00           122,825.27        1,707,892.83
    其他长期资产
    无形资产及其他资产合计               32,253,406.46        33,816,082.15        16,652,984.77       18,330,809.75
    递延税项：
    递延税款借项
    资产总计                          1,727,538,242.53     1,716,518,776.31     1,306,228,917.53    1,292,951,435.18
    流动负债：
    短期借款                            202,005,421.95       198,876,780.14       121,809,190.95      113,814,904.74
    应付票据                            263,293,910.08       245,219,372.35        57,655,602.48       50,692,004.36
    应付账款                            124,684,110.32       160,825,913.25        63,761,576.40       87,741,200.01
    预收账款                              1,988,846.36         6,651,247.63           245,651.96        4,712,559.55
    应付工资                              6,638,605.61        12,345,865.94         4,505,113.74        9,781,667.01
    应付福利费                            4,394,121.96         4,844,154.68         3,225,141.63        3,850,721.93
    应付股利
    应交税金                              7,334,882.65        16,875,424.08        14,314,085.94        9,135,250.76
    其他应交款                            1,320,130.08         1,217,285.53           762,642.71          668,593.81
    其他应付款                           35,383,609.88        39,835,835.69        21,437,223.58       21,893,263.21
    预提费用                              1,099,360.88         1,320,127.97           674,487.96          782,703.64
    预计负债
    一年内到期的长期负债                 20,035,200.00        20,035,200.00        20,035,200.00       20,035,200.00
    其他流动负债
    流动负债合计                        668,178,199.77       708,047,207.26       308,425,917.35      323,108,069.02
    长期负债：
    长期借款                             80,105,600.00        60,105,600.00        60,105,600.00       60,105,600.00
    应付债券
    长期应付款
    专项应付款                            1,751,403.62         2,562,631.29         1,474,003.39        2,276,147.50
    其他长期负债
    长期负债合计                         81,857,003.62        62,668,231.29        61,579,603.39       62,381,747.50
    递延税项：
    递延税款贷项
    负债合计                            750,035,203.39       770,715,438.55       370,005,520.74      385,489,816.52
    少数股东权益                         38,523,385.45        37,097,873.32
    所有者权益（或股东权益）：
    实收资本（或股本）                  270,366,165.00       270,366,165.00       270,366,165.00      270,366,165.00
    减：已归还投资
    实收资本（或股本）净额              270,366,165.00       270,366,165.00       270,366,165.00      270,366,165.00
    资本公积                            465,332,643.70       465,294,033.70       465,612,173.88      465,573,563.88
    盈余公积                             73,656,536.26        59,594,539.59        73,656,536.26       59,594,539.59
    其中：法定公益金                     16,583,092.82        16,583,092.82        16,583,092.82       16,583,092.82
    未分配利润                          129,624,308.73       113,450,726.15       126,588,521.65      111,927,350.19
    拟分配现金股利                       32,443,939.80        32,443,939.80        32,443,939.80       32,443,939.80
    外币报表折算差额
    减：未确认投资损失
    所有者权益（或股东权益）合
                                        938,979,653.69       908,705,464.44       936,223,396.79      907,461,618.66
    计
    负债和所有者权益（或股东权
                                     1,727,538,242.53      1,716,518,776.31     1,306,228,917.53    1,292,951,435.18
    益）总计
   公司法定代表人:吴梦根主管会计工作负责人:陈俊标会计机构负责人:杨春芳
                                                  利润及利润分配表
                                                    2006年1-3月
   编制单位:浙江升华拜克生物股份有限公司
                                                                    单位:元币种:人民币审计类型:未经审计
                                                            合并                                母公司
                     项目
                                                  本期数          上年同期数           本期数          上年同期数
    一、主营业务收入                           386,042,303.11    370,479,219.07     214,222,895.35    181,933,612.21
    减：主营业务成本                           328,710,312.40    305,331,684.90     176,140,967.62    141,757,005.06
    主营业务税金及附加                           1,233,758.78      1,127,813.32       1,233,758.78      1,006,934.65
    二、主营业务利润（亏损以“-”号填
                                               56,098,231.93      64,019,720.85      36,848,168.95     39,169,672.50
    列）
    加：其他业务利润（亏损以“-”号填
                                                1,246,793.22         510,636.17       1,313,916.42        767,041.46
    列）
    减:营业费用                                  6,189,362.39     10,774,907.55       3,494,309.10      5,918,573.14
    管理费用                                    24,194,184.97     20,771,372.46      16,862,752.80     15,551,436.07
    财务费用                                     3,126,129.94      2,745,692.59         506,385.95      1,185,108.81
    三、营业利润（亏损以“-”号填列）           23,835,347.85     30,238,384.42      17,298,637.52     17,281,595.94
    加：投资收益（损失以“-”号填列）            1,673,508.61       -292,762.11       3,818,170.51      5,333,940.28
    补贴收入                                                         350,475.48
    营业外收入                                         600.00          1,003.85             600.00          1,003.85
    减：营业外支出                                 545,869.72        106,533.90         423,075.92         48,090.11
    四、利润总额（亏损总额以“-”号填
                                               24,963,586.74      30,190,567.74      20,694,332.11     22,568,449.96
    列）
    减：所得税                                   8,089,032.34     11,154,393.46       6,033,160.65      6,687,745.05
    减：少数股东损益                               700,971.82        940,258.73
    加：未确认投资损失(合并报表填列)
    五、净利润（亏损以“-”号填列）             16,173,582.58     18,095,915.55      14,661,171.46     15,880,704.91
    加：年初未分配利润                         113,450,726.15     79,393,157.81     111,927,350.19     79,305,062.58
    其他转入
    六、可供分配的利润                         129,624,308.73     97,489,073.36     126,588,521.65     95,185,767.49
    减：提取法定盈余公积
    提取法定公益金
    提取职工奖励及福利基金(合并报表填
    列)
    提取储备基金
    提取企业发展基金
    利润归还投资
    七、可供股东分配的利润                     129,624,308.73     97,489,073.36     126,588,521.65     95,185,767.49
    减：应付优先股股利
    提取任意盈余公积
    应付普通股股利
    转作股本的普通股股利
    八、未分配利润(未弥补亏损以“-”号
                                              129,624,308.73      97,489,073.36     126,588,521.65     95,185,767.49
    填列)
   公司法定代表人:吴梦根主管会计工作负责人:陈俊标会计机构负责人:杨春芳
                                                      现金流量表
                                                    2006年1-3月
   编制单位:浙江升华拜克生物股份有限公司
                                                                      单位:元币种:人民币审计类型:未经审计
                             项目                                        合并                       母公司
    一、经营活动产生的现金流量：
    销售商品、提供劳务收到的现金                                         334,389,502.31               188,069,022.30
    收到的税费返还                                                        14,748,319.08                 2,288,099.52
    收到的其他与经营活动有关的现金                                        37,198,370.57                 7,726,509.55
    现金流入小计                                                         386,336,191.96               198,083,631.37
    购买商品、接受劳务支付的现金                                         336,397,422.54               150,426,743.57
    支付给职工以及为职工支付的现金                                        22,452,208.11                17,799,489.26
    支付的各项税费                                                         6,206,466.69                 4,986,460.17
    支付的其他与经营活动有关的现金                                        46,206,613.72                19,682,350.82
    现金流出小计                                                         411,262,711.06               192,895,043.82
    经营活动产生的现金流量净额                                           -24,926,519.10                 5,188,587.55
    二、投资活动产生的现金流量：
    收回投资所收到的现金                                                   5,498,282.25                 5,498,282.25
    其中：出售子公司收到的现金
    取得投资收益所收到的现金
    处置固定资产、无形资产和其他长期资产而收回的现金                         234,720.00                   234,720.00
    收到的其他与投资活动有关的现金                                         1,000,000.00                 1,000,000.00
    现金流入小计                                                           6,733,002.25                 6,733,002.25
    购建固定资产、无形资产和其他长期资产所支付的现金                      42,697,601.43                32,240,954.82
    投资所支付的现金
    支付的其他与投资活动有关的现金
    现金流出小计                                                          42,697,601.43                32,240,954.82
    投资活动产生的现金流量净额                                           -35,964,599.18               -25,507,952.57
    三、筹资活动产生的现金流量：
    吸收投资所收到的现金
    其中：子公司吸收少数股东权益性投资收到的现金
    借款所收到的现金                                                     117,389,109.33                62,507,000.93
    收到的其他与筹资活动有关的现金
    现金流入小计                                                         117,389,109.33                62,507,000.93
    偿还债务所支付的现金                                                  93,806,699.88                54,058,947.08
    分配股利、利润或偿付利息所支付的现金                                   4,525,075.35                 2,755,098.77
    其中：支付少数股东的股利
    支付的其他与筹资活动有关的现金                                         1,209,800.00                 1,209,800.00
    其中：子公司依法减资支付给少数股东的现金
    现金流出小计                                                          99,541,575.23                58,023,845.85
    筹资活动产生的现金流量净额                                            17,847,534.10                 4,483,155.08
    四、汇率变动对现金的影响                                                -281,840.72                  -107,392.59
    五、现金及现金等价物净增加额                                         -43,325,424.90               -15,943,602.53
    补充材料
    1、将净利润调节为经营活动现金流量：
    净利润                                                                16,173,582.58                14,661,171.46
    加：少数股东损益(亏损以“-”号填列)                                      700,971.82
    减：未确认的投资损失
    加：计提的资产减值准备                                                 5,968,926.16                 2,855,497.63
    固定资产折旧                                                          17,300,284.33                15,123,019.58
    无形资产摊销                                                             280,848.64                    92,757.42
    长期待摊费用摊销                                                       2,241,828.10                 2,241,828.10
    待摊费用减少（减：增加）                                                 409,832.34                   443,695.24
    预提费用增加（减：减少）                                                -350,743.49
    处理固定资产、无形资产和其他长期资产的损失(减:收
                                                                             155,842.66                   155,842.66
    益)
    固定资产报废损失
    财务费用                                                               4,698,700.39                 2,754,275.68
    投资损失（减：收益）                                                  -1,673,508.61                -3,818,170.51
    递延税款贷项（减：借项）
    存货的减少（减：增加）                                                17,816,038.12                18,477,679.30
    经营性应收项目的减少(减：增加)                                       -72,568,387.65               -36,398,479.71
    经营性应付项目的增加(减：减少)                                       -16,080,734.49               -11,400,529.30
    其他
    经营活动产生的现金流量净额                                           -24,926,519.10                 5,188,587.55
    2．不涉及现金收支的投资和筹资活动：
    债务转为资本
    一年内到期的可转换公司债券
    融资租入固定资产
    3、现金及现金等价物净增加情况：
    现金的期末余额                                                       151,283,582.03                37,301,617.82
    减：现金的期初余额                                                   194,609,006.93                53,245,220.35
    加：现金等价物的期末余额
    减：现金等价物的期初余额
    现金及现金等价物净增加额                                             -43,325,424.90               -15,943,602.53
   公司法定代表人:吴梦根主管会计工作负责人:陈俊标会计机构负责人:杨春芳